CUL4B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.148800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.836200E-01
Normal-vs-Stage2
7.829200E-01
Normal-vs-Stage3
2.057000E-01
Normal-vs-Stage4
7.402200E-01
Stage1-vs-Stage2
6.781800E-01
Stage1-vs-Stage3
3.898400E-02
Stage1-vs-Stage4
5.992600E-01
Stage2-vs-Stage3
1.854820E-01
Stage2-vs-Stage4
4.471800E-01
Stage3-vs-Stage4
6.223600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.121000E-01
Normal-vs-AfricanAmerican
8.846400E-01
Normal-vs-Asian
6.584800E-01
Caucasian-vs-AfricanAmerican
8.821400E-01
Caucasian-vs-Asian
4.503000E-01
AfricanAmerican-vs-Asian
6.117200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.582400E-01
Normal-vs-Female
8.966600E-01
Male-vs-Female
5.036600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.969400E-01
Normal-vs-Age(41-60Yrs)
5.908400E-01
Normal-vs-Age(61-80Yrs)
5.395600E-01
Normal-vs-Age(81-100Yrs)
4.215200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.990000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.593800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.150600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.90689999999672E-05
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.933660E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.360600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.142000E-01
Normal-vs-Daily Drinker
7.892000E-01
Normal-vs-Weekly Drinker
4.312400E-01
Normal-vs-Occasional Drinker
6.412000E-01
Normal-vs-Social Drinker
8.283400E-01
Non Drinker-vs-Daily Drinker
4.822600E-01
Non Drinker-vs-Weekly Drinker
9.657200E-01
Non Drinker-vs-Occasional Drinker
2.615800E-02
Non Drinker-vs-Social Drinker
1.082010E-01
Daily Drinker-vs-Weekly Drinker
5.200600E-01
Daily Drinker-vs-Occasional Drinker
1.735220E-01
Daily Drinker-vs-Social Drinker
3.760200E-01
Weekly Drinker-vs-Occasional Drinker
3.590200E-02
Weekly Drinker-vs-Social Drinker
1.452000E-01
Occasional Drinker-vs-Social Drinker
7.646600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.879400E-01
Normal-vs-Grade 2
6.200200E-01
Normal-vs-Grade 3
8.830300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.565000E-01
Grade 1-vs-Grade 3
1.579640E-01
Grade 1-vs-Grade 4
2.879400E-01
Grade 2-vs-Grade 3
1.784760E-01
Grade 2-vs-Grade 4
6.200200E-01
Grade 3-vs-Grade 4
8.830300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.252800E-01
Normal-vs-NonDiabetic
8.151000E-01
Diabetic-vs-NonDiabetic
2.582400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.296400E-01
Normal-vs-NoPancreatitis
7.747800E-01
Pancreatitis-vs-NoPancreatitis
9.598600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.286400E-01
Normal-vs-N1
8.203600E-01
N0-vs-N1
9.667800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.475800E-01
Normal-vs-TP53-NonMutant
9.444000E-01
TP53-Mutant-vs-TP53-NonMutant
1.889380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
